(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.
The three biggest winners today are ARCHER, SODITECH, and GROUPE JAJ.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| ARCHER (ARCH.OL) | 1.08 | 21.06% | 2024-03-08 12:24:44 |
| SODITECH (SEC.PA) | 1.47 | 12.21% | 2024-03-08 13:23:01 |
| GROUPE JAJ (GJAJ.PA) | 1.34 | 11.67% | 2024-03-08 13:04:33 |
| STEF (STF.PA) | 136.60 | 9.63% | 2024-03-08 13:23:19 |
| ELECT. MADAGASCAR (EEM.PA) | 3.60 | 9.09% | 2024-03-08 13:02:34 |
| GENSIGHT BIOLOGICS (SIGHT.PA) | 0.46 | 8.65% | 2024-03-08 13:04:21 |
| AUTOSTORE HOLDINGS (AUTO.OL) | 18.23 | 7.97% | 2024-03-08 12:25:01 |
| VALNEVA (VLA.PA) | 3.37 | 7.69% | 2024-03-08 13:24:21 |
| MOREFIELD GROUP (MORE.AS) | 0.42 | 7.18% | 2024-03-08 12:03:20 |
| RUBIS (RUI.PA) | 27.02 | 6.88% | 2024-03-08 13:22:08 |
The three biggest losers today are SAS AB, MITHRA, and PIERRE VAC BSA ACT.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| SAS AB (SASNO.OL) | 0.03 | -25.82% | 2024-03-08 12:42:58 |
| MITHRA (MITRA.BR) | 0.24 | -20% | 2024-03-08 12:20:44 |
| PIERRE VAC BSA ACT (VACBS.PA) | 0.09 | -16.67% | 2024-03-08 13:21:26 |
| ASETEK (ASTK.OL) | 7.06 | -10.63% | 2024-03-08 12:24:52 |
| VIVORYON (VVY.AS) | 0.54 | -9.33% | 2024-03-08 12:04:55 |
| BE SEMICONDUCTOR (BESI.AS) | 161.75 | -9.13% | 2024-03-08 12:01:09 |
| ULTIMOVACS (ULTI.OL) | 7.97 | -8.39% | 2024-03-08 12:44:19 |
| TOUR EIFFEL (EIFF.PA) | 9.86 | -7.42% | 2024-03-08 13:24:00 |
| BELYSSE GROUP (BELYS.BR) | 0.76 | -7.32% | 2024-03-08 12:05:38 |
| EUTELSAT COMMUNIC. (ETL.PA) | 3.65 | -6.75% | 2024-03-08 13:03:09 |
Winners today
1. ARCHER (ARCH.OL)
21.06% Price Change
Archer Limited, an oilfield service company, provides various oilfield products and services to the oil and gas industry. The company operates through two segments, Eastern Hemisphere and Western Hemisphere. It provides oiltools, such as plugs and abandonment (P&A), slot recovery and P&A, cementing, and well cleaning solutions; digital well integrity solutions; land drilling and platform drilling services; mobile offshore drilling unit management services; and modular drilling rigs. The company also offers engineering services, such as project management, construction and installations, multidiscipline engineering, consulting, and inspection services. In addition, it provides wireline services, including cased hole logging, conveyance and mechanical/slickline, research and development, and technology development services. Further, the company offers equipment rental, production monitoring, well imaging, and integrity management tools services. It operates in North America, South America, Europe, and internationally. The company was formerly known as Seawell Limited and changed its name to Archer Limited in May 2011. Archer Limited was incorporated in 2007 and is based in Sandnes, Norway.
Oslo Børs Benchmark Index_GI ended the session with ARCHER rising 21.06% to €1.08 on Friday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI jumped 0.37% to €1,279.23, following the last session’s upward trend on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, ARCHER has a trailing twelve months EPS of kr0.69.
PE Ratio
ARCHER has a trailing twelve months price to earnings ratio of 1.56. Meaning, the purchaser of the share is investing kr1.56 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -14.89%.
Volatility
ARCHER’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.67%, a negative 0.33%, and a positive 1.97%.
ARCHER’s highest amplitude of average volatility was 1.01% (last week), 1.73% (last month), and 1.97% (last quarter).
Moving Average
ARCHER’s worth is way above its 50-day moving average of kr0.89 and way under its 200-day moving average of kr2.17.
More news about ARCHER.
2. SODITECH (SEC.PA)
12.21% Price Change
Soditech SA engages in the integration of mechanical, thermal, and electronic sub-assemblies in space, research, and defense fields in France. It designs structural sub-assemblies and integrates optical and thermal equipment, such as OSRs, SSMs, heaters, and heat pipes; designs and manufactures multi-layer insulation products; and designs, manufactures, and tests space harnesses on instruments or platforms. The company also provides calculation services, such as static, dynamic, thermal, and thermoelastic; designs assembly tools; and designs and produces super insulating multi-layer mattresses for ultra-vacuum areas. In addition, it develops, qualifies, manufactures, and tests embedded cabinets; and designs, assembles, and tests racks and test equipment racks. The company was formerly known as Soditech Ingenierie SA. Soditech SA was founded in 1990 and is headquartered in Aix-en-Provence, France.
CAC 40 ended the session with SODITECH rising 12.21% to €1.47 on Friday, after four successive sessions in a row of losses. CAC 40 jumped 0.15% to €8,028.01, after two consecutive sessions in a row of gains, on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, SODITECH has a trailing twelve months EPS of €0.07.
PE Ratio
SODITECH has a trailing twelve months price to earnings ratio of 21. Meaning, the purchaser of the share is investing €21 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.59%.
Yearly Top and Bottom Value
SODITECH’s stock is valued at €1.47 at 21:40 EST, way under its 52-week high of €1.73 and way above its 52-week low of €1.01.
Volume
Today’s last reported volume for SODITECH is 100 which is 76.19% below its average volume of 420.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, SODITECH’s stock is considered to be overbought (>=80).
Volatility
SODITECH’s last week, last month’s, and last quarter’s current intraday variation average was a negative 6.04%, a negative 0.06%, and a positive 8.78%.
SODITECH’s highest amplitude of average volatility was 6.04% (last week), 9.52% (last month), and 8.78% (last quarter).
More news about SODITECH.
3. GROUPE JAJ (GJAJ.PA)
11.67% Price Change
Groupe JAJ distributes clothing products. It offers clothing products of the SCHOTT brand. The company was formerly known as JAJ Distribution. The company is headquartered in Montreuil, France.
CAC 40 ended the session with GROUPE JAJ jumping 11.67% to €1.34 on Friday, after five successive sessions in a row of losses. CAC 40 rose 0.15% to €8,028.01, after two successive sessions in a row of gains, on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, GROUPE JAJ has a trailing twelve months EPS of €0.15.
PE Ratio
GROUPE JAJ has a trailing twelve months price to earnings ratio of 8.93. Meaning, the purchaser of the share is investing €8.93 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 56.17%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Nov 15, 2005, the estimated forward annual dividend yield is 2.92%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 39.6%, now sitting on 21.14M for the twelve trailing months.
Volume
Today’s last reported volume for GROUPE JAJ is 8 which is 98.78% below its average volume of 656.
Yearly Top and Bottom Value
GROUPE JAJ’s stock is valued at €1.34 at 21:40 EST, way below its 52-week high of €1.76 and higher than its 52-week low of €1.30.
More news about GROUPE JAJ.
4. STEF (STF.PA)
9.63% Price Change
STEF SA provides temperature-controlled road transport and logistics services for agri-food industry, and out-of-home foodservices. It transports fresh, frozen, and thermosensitive products; and seafood products. The company also provides maritime passenger and freight transport services between Marseille and Corsica; and co-packing services. It operates in France, Italy, Spain, Portugal, Belgium, the Netherlands, Switzerland, and the United Kingdom. The company was founded in 1920 and is headquartered in Paris, France.
CAC 40 ended the session with STEF jumping 9.63% to €136.60 on Friday while CAC 40 rose 0.15% to €8,028.01.
Earnings Per Share
As for profitability, STEF has a trailing twelve months EPS of €14.05.
PE Ratio
STEF has a trailing twelve months price to earnings ratio of 9.72. Meaning, the purchaser of the share is investing €9.72 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.17%.
Moving Average
STEF’s worth is way above its 50-day moving average of €114.62 and way above its 200-day moving average of €108.82.
Sales Growth
STEF’s sales growth for the current quarter is negative 2.6%.
More news about STEF.
5. ELECT. MADAGASCAR (EEM.PA)
9.09% Price Change
Electricité et Eaux de Madagascar Société Anonyme engages in the luxury hotel business in Cambodia. It is also involved in the real estate, paper, and casino businesses. The company was formerly known as Viktoria Invest SA and changed its name to Electricité et Eaux de Madagascar Société Anonyme in January 2019. The company was founded in 1928 and is based in Paris, France.
CAC 40 ended the session with ELECT. MADAGASCAR jumping 9.09% to €3.60 on Friday while CAC 40 rose 0.15% to €8,028.01.
Earnings Per Share
As for profitability, ELECT. MADAGASCAR has a trailing twelve months EPS of €-0.44.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -15.14%.
More news about ELECT. MADAGASCAR.
6. GENSIGHT BIOLOGICS (SIGHT.PA)
8.65% Price Change
GenSight Biologics S.A., a clinical-stage biotechnology company, discovers, develops, and commercializes therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system. The company develops its products through gene therapy-based mitochondrial targeting sequence and optogenetics technology platforms. Its lead product candidates include LUMEVOQ (GS010), a recombinant AAV2-based gene therapy, which is in Phase III clinical trials for the treatment of leber hereditary optic neuropathy caused by a mutated ND4 gene; and GS030, which is in Phase I/II clinical trial for the treatment of retinitis pigmentosa, as well as in preclinical stage to treat dry age-related macular degeneration. The company is also developing products that are in preclinical stage targeting ophthalmic and neurodegenerative diseases. The company was incorporated in 2012 and is headquartered in Paris, France.
CAC 40 ended the session with GENSIGHT BIOLOGICS jumping 8.65% to €0.46 on Friday, after three sequential sessions in a row of losses. CAC 40 jumped 0.15% to €8,028.01, after two consecutive sessions in a row of gains, on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, GENSIGHT BIOLOGICS has a trailing twelve months EPS of €-0.63.
Volume
Today’s last reported volume for GENSIGHT BIOLOGICS is 234713 which is 44.85% above its average volume of 162035.
More news about GENSIGHT BIOLOGICS.
7. AUTOSTORE HOLDINGS (AUTO.OL)
7.97% Price Change
AutoStore Holdings Ltd., a robotic and software technology company, provides warehouse automation solutions in Norway, rest of Nordics, Germany, rest of Europe, the United States, Asia, and internationally. It offers grids, ports, bins, robots, workstations, controllers, and spare parts. The company also provides Qublt Fulfillment Platform, a warehouse management software; PickUpPort, a public-facing port that enables contactless in-store pickup; R5+, a robot based on the technology product; ASIO 3.0, a safety component; Bin Lift 2.0, a redesigned vertical lift for bins; and Unify Analytics, a cloud-based service and data platform that simplifies the aggregation and presentation of metrics. It serves retail, grocery, third party logistic, industrial, and healthcare industries. The company was formerly known as AutoStore NewCo Ltd. and changed its name to AutoStore Holdings Ltd. in October 2021. AutoStore Holdings Ltd. was founded in 1996 and is headquartered in Nedre Vats, Norway.
Oslo Børs Benchmark Index_GI ended the session with AUTOSTORE HOLDINGS jumping 7.97% to €18.23 on Friday while Oslo Børs Benchmark Index_GI rose 0.37% to €1,279.23.
Earnings Per Share
As for profitability, AUTOSTORE HOLDINGS has a trailing twelve months EPS of kr-0.15.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.2%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
AUTOSTORE HOLDINGS’s EBITDA is 110.68.
Volume
Today’s last reported volume for AUTOSTORE HOLDINGS is 3109390 which is 44.28% above its average volume of 2154990.
More news about AUTOSTORE HOLDINGS.
8. VALNEVA (VLA.PA)
7.69% Price Change
Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera and/or heat-labile toxin producing enterotoxigenic Escherichia coli bacterium; and VLA2001, an inactivated whole-virus COVID-19 vaccine. The company also develops VLA15, a vaccine candidate, which is in Phase III clinical trial against Borrelia, the bacterium that causes Lyme disease; VLA1553, a vaccine candidate, which is in Phase III clinical trial against the chikungunya virus; VLA1554, a vaccine candidate targeting human metapneumovirus; and VLA2112, a vaccine candidate to treat patients with epstein-barr virus. It sells its products in the United States, Canada, Germany, Austria, Nordics, the United Kingdom, France, rest of European countries, and internationally. Valneva SE has collaborations with Pfizer, Inc. to co-develop and commercialize its Lyme disease vaccine; and Instituto Butantan for the development, manufacturing, and marketing of single-shot chikungunya vaccine. The company was founded in 1998 and is based in Saint-Herblain, France.
CAC 40 ended the session with VALNEVA rising 7.69% to €3.37 on Friday while CAC 40 jumped 0.15% to €8,028.01.
Earnings Per Share
As for profitability, VALNEVA has a trailing twelve months EPS of €-0.82.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.81%.
Sales Growth
VALNEVA’s sales growth is negative 76.3% for the present quarter and negative 58.9% for the next.
Volatility
VALNEVA’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.19%, a negative 0.92%, and a positive 2.37%.
VALNEVA’s highest amplitude of average volatility was 2.36% (last week), 2.70% (last month), and 2.37% (last quarter).
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Jan 1, 1970, the estimated forward annual dividend yield is 3.35%.
More news about VALNEVA.
9. MOREFIELD GROUP (MORE.AS)
7.18% Price Change
Morefield Group N.V. through its subsidiary Kersten Groep BV, engages in the selecting, advising, supplying, and maintaining medical aids for physical disability peoples. The company manufactures orthoses, such as braces and splints. It serves to municipalities, care administration offices, health insurers, and care institutions/care organizations. The company was formerly known as HeadFirst Source Group N.V. and changed its name to Morefield Group N.V. in January 2019. Morefield Group N.V. was incorporated in 1983 and is headquartered in Willemstad, Curaçao.
AEX-Index ended the session with MOREFIELD GROUP rising 7.18% to €0.42 on Friday while AEX-Index dropped 0.78% to €861.96.
Earnings Per Share
As for profitability, MOREFIELD GROUP has a trailing twelve months EPS of €0.1.
PE Ratio
MOREFIELD GROUP has a trailing twelve months price to earnings ratio of 4.18. Meaning, the purchaser of the share is investing €4.18 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 43.55%.
Volume
Today’s last reported volume for MOREFIELD GROUP is 2957 which is 49.52% below its average volume of 5858.
Moving Average
MOREFIELD GROUP’s worth is above its 50-day moving average of €0.41 and way above its 200-day moving average of €0.34.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, MOREFIELD GROUP’s stock is considered to be overbought (>=80).
More news about MOREFIELD GROUP.
10. RUBIS (RUI.PA)
6.88% Price Change
Rubis engages in the operation of bulk liquid storage facilities for commercial and industrial customers in Europe, Africa, and the Caribbean. The company operates through Retail & Marketing, Support & Services, and Renewable Electricity production segments. It operates terminals that provide bulk liquid storage facilities for fuels, chemicals, and agri-food products; and distributes fuels, liquefied gases, bitumen, and lubricants. The company also provides infrastructure, transportation, supply, and services for supporting the development of downstream distribution and marketing activities; and produces photovoltaic electricity. Rubis was incorporated in 1954 and is headquartered in Paris, France.
CAC 40 ended the session with RUBIS jumping 6.88% to €27.02 on Friday, following the last session’s upward trend. CAC 40 jumped 0.15% to €8,028.01, after two successive sessions in a row of gains, on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, RUBIS has a trailing twelve months EPS of €3.42.
PE Ratio
RUBIS has a trailing twelve months price to earnings ratio of 7.9. Meaning, the purchaser of the share is investing €7.9 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.87%.
More news about RUBIS.
Losers Today
1. SAS AB (SASNO.OL)
-25.82% Price Change
SAS AB (publ), together with its subsidiaries, provides passenger flight transportation services in the Nordic and international route network. The company also offers air cargo services, in-flight sales, ground handling, and technical maintenance services, as well as travel-related loyalty programs. It operates a fleet of 134 aircraft, including 16 long-haul aircraft, 87 short-haul aircraft, and 31 aircraft flown by regional production partners. The company was founded in 1946 and is headquartered in Stockholm, Sweden. On July 5, 2022, SAS AB (publ), along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of New York.
Oslo Børs Benchmark Index_GI ended the session with SAS AB falling 25.82% to €0.03 on Friday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI jumped 0.37% to €1,279.23, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, SAS AB has a trailing twelve months EPS of kr-0.8.
More news about SAS AB.
2. MITHRA (MITRA.BR)
-20% Price Change
Mithra Pharmaceuticals SA develops, manufactures, and markets complex therapeutics in the areas of contraception, menopause, and hormone-dependent cancers in Belgium, Europe and internationally. Its development candidates include Estelle, a combined oral contraceptive that has completed phase III clinical trial; Donesta, which is in phase III clinical trial for estetrol-based oral hormone treatment; and products for neuroprotection and wound healing. The company also develops Myring, a contraceptive vaginal ring releasing a combination of hormones; Tibelia, a tablet composed of tibolone and a synthetic steroid used for hormone therapy in menopause; and Zoreline, a biodegradable subcutaneous implant for use in prostate and breast cancers, and benign gynecological indications. In addition, it provides products in polymeric forms, implants, sterile injectable products, and hormonal tablets. The company was founded in 1999 and is headquartered in Liège, Belgium.
BEL 20 ended the session with MITHRA falling 20% to €0.24 on Friday, after four sequential sessions in a row of losses. BEL 20 jumped 0.42% to €3,733.99, after two successive sessions in a row of gains, on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, MITHRA has a trailing twelve months EPS of €-1.41.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -575.59%.
Yearly Top and Bottom Value
MITHRA’s stock is valued at €0.24 at 21:40 EST, way below its 52-week low of €0.50.
Moving Average
MITHRA’s worth is way below its 50-day moving average of €0.94 and way under its 200-day moving average of €1.57.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, MITHRA’s stock is considered to be overbought (>=80).
Revenue Growth
Year-on-year quarterly revenue growth declined by 38.1%, now sitting on 62.67M for the twelve trailing months.
More news about MITHRA.
3. PIERRE VAC BSA ACT (VACBS.PA)
-16.67% Price Change
CAC 40 ended the session with PIERRE VAC BSA ACT sliding 16.67% to €0.09 on Friday while CAC 40 jumped 0.15% to €8,028.01.
Yearly Top and Bottom Value
PIERRE VAC BSA ACT’s stock is valued at €0.09 at 21:40 EST, below its 52-week low of €0.10.
More news about PIERRE VAC BSA ACT.
4. ASETEK (ASTK.OL)
-10.63% Price Change
Asetek A/S, together with its subsidiaries, engages in the designing, developing, and marketing of liquid cooling solutions in Asia, Europe, and the Americas. The company operates through Liquid cooling, Data center and SimSports segments. Its products are used in personal computers, servers, and data centers to provide improved performance, acoustics, and energy efficiency. It serves original equipment manufacturers, resellers, and channel partners. The company was founded in 1997 and is headquartered in Aalborg, Denmark.
Oslo Børs Benchmark Index_GI ended the session with ASETEK sliding 10.63% to €7.06 on Friday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI jumped 0.37% to €1,279.23, following the last session’s upward trend on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, ASETEK has a trailing twelve months EPS of kr-0.04.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.33%.
Moving Average
ASETEK’s value is way under its 50-day moving average of kr8.29 and way under its 200-day moving average of kr9.69.
Revenue Growth
Year-on-year quarterly revenue growth grew by 45.2%, now sitting on 59.15M for the twelve trailing months.
More news about ASETEK.
5. VIVORYON (VVY.AS)
-9.33% Price Change
Vivoryon Therapeutics N.V., a clinical stage biopharmaceutical company, engages in the research, development, and commercialize small molecule-based medicines. Its pipeline products target toxic pyroglutamate-Abeta (pGlu-Abeta), which inhibits the production of pGlu-Abeta. The company's lead product candidate is PQ912, a nanomolar QPCT inhibitor that has completed Phase IIb clinical trials for use in the treatment of Alzheimer's disease. In addition, the company is developing a monoclonal antibody PBD-C06 is for N3pE-Abeta. Vivoryon Therapeutics N.V. has a collaboration agreement with Nordic Bioscience for the clinical development of PQ912 for Alzheimer's disease; and research collaboration with the Fraunhofer Institute for cell therapy and immunology, as well as a strategic regional licensing partnership with Simcere Pharmaceutical Group Ltd. to develop and commercialize medicines targeting the neurotoxic amyloid species N3pE (pGlu-Abeta) to treat Alzheimer's disease. Vivoryon Therapeutics N.V. was founded in 1997 and is headquartered in Halle, Germany.
AEX-Index ended the session with VIVORYON sliding 9.33% to €0.54 on Friday while AEX-Index dropped 0.78% to €861.96.
Earnings Per Share
As for profitability, VIVORYON has a trailing twelve months EPS of €-0.11.
Volatility
VIVORYON’s last week, last month’s, and last quarter’s current intraday variation average was a negative 10.26%, a negative 1.88%, and a positive 2.59%.
VIVORYON’s highest amplitude of average volatility was 10.26% (last week), 3.14% (last month), and 2.59% (last quarter).
Volume
Today’s last reported volume for VIVORYON is 832743 which is 80.85% above its average volume of 460459.
More news about VIVORYON.
6. BE SEMICONDUCTOR (BESI.AS)
-9.13% Price Change
BE Semiconductor Industries N.V. engages in the development, manufacture, marketing, sale, and service of semiconductor assembly equipment for the semiconductor and electronics industries worldwide. The company's principal products include die attach equipment, such as single chip, multi-chip, multi module, flip chip, thermal compression bonding, fan out wafer level packaging, hybrid and embedded bridge die bonding, and die sorting systems; and packaging equipment, including conventional, ultra-thin, and wafer level molding, as well as trim and form, and singulation systems. Its principal products also comprise plating equipment, such as tin, copper, and precious metal and solar plating systems, as well as related process chemicals; and tooling, conversion kits, spare parts, and other services. The company's principal brand names include Datacon, Esec, Fico, and Meco. It offers its products primarily to multinational chip manufacturers, assembly subcontractors, and electronics and industrial companies. The company was incorporated in 1995 and is headquartered in Duiven, the Netherlands.
AEX-Index ended the session with BE SEMICONDUCTOR sliding 9.13% to €161.75 on Friday, after two successive sessions in a row of gains. AEX-Index dropped 0.78% to €861.96, after two sequential sessions in a row of gains, on what was a somewhat bearish trend exchanging session today.
Earnings Per Share
As for profitability, BE SEMICONDUCTOR has a trailing twelve months EPS of €2.23.
PE Ratio
BE SEMICONDUCTOR has a trailing twelve months price to earnings ratio of 72.53. Meaning, the purchaser of the share is investing €72.53 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 33.73%.
Sales Growth
BE SEMICONDUCTOR’s sales growth is 16.1% for the ongoing quarter and 21.7% for the next.
Moving Average
BE SEMICONDUCTOR’s worth is way higher than its 50-day moving average of €145.24 and way above its 200-day moving average of €115.47.
Volatility
BE SEMICONDUCTOR’s last week, last month’s, and last quarter’s current intraday variation average was 1.43%, 0.77%, and 1.97%.
BE SEMICONDUCTOR’s highest amplitude of average volatility was 3.19% (last week), 2.84% (last month), and 1.97% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BE SEMICONDUCTOR’s stock is considered to be oversold (<=20).
More news about BE SEMICONDUCTOR.
7. ULTIMOVACS (ULTI.OL)
-8.39% Price Change
Ultimovacs ASA, a biotech company, develops immunotherapies against cancers. Its lead product candidate is UV1, a peptide-based cancer vaccine that induces a specific T cell response against the universal cancer antigen telomerase. The company was incorporated in 2011 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with ULTIMOVACS sliding 8.39% to €7.97 on Friday while Oslo Børs Benchmark Index_GI jumped 0.37% to €1,279.23.
Earnings Per Share
As for profitability, ULTIMOVACS has a trailing twelve months EPS of kr-6.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -51.94%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ULTIMOVACS’s stock is considered to be overbought (>=80).
Yearly Top and Bottom Value
ULTIMOVACS’s stock is valued at kr7.97 at 21:40 EST, way under its 52-week low of kr67.90.
Moving Average
ULTIMOVACS’s value is way under its 50-day moving average of kr130.87 and way below its 200-day moving average of kr101.89.
Earnings Before Interest, Taxes, Depreciation, and Amortization
ULTIMOVACS’s EBITDA is -63.1.
More news about ULTIMOVACS.
8. TOUR EIFFEL (EIFF.PA)
-7.42% Price Change
Société de la Tour Eiffel is an integrated property company with EUR 1.8 bn in assets and a powerful service culture. This agile company operates in various asset classes, including offices, urban logistics, managed residential and retail, in Greater Paris and other major French metropolitan areas. An active player throughout the property cycle, it assists its tenants – companies of all sizes and sectors – through high-standard direct management of its properties. Société de la Tour Eiffel conducts a pro-active and transversal CSR policy that is an integral part of its strategic orientations. Société de la Tour Eiffel is listed on Euronext Paris (B board) – ISIN code: FR0000036816 – Reuters: TEIF.PA – Bloomberg: EIFF.FP – Member of the IEIF Foncières and IEIF Immobilier France indices.
CAC 40 ended the session with TOUR EIFFEL sliding 7.42% to €9.86 on Friday, following the last session’s upward trend. CAC 40 rose 0.15% to €8,028.01, after two sequential sessions in a row of gains, on what was a somewhat up trend exchanging session today.
Earnings Per Share
As for profitability, TOUR EIFFEL has a trailing twelve months EPS of €-0.65.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.54%.
More news about TOUR EIFFEL.
9. BELYSSE GROUP (BELYS.BR)
-7.32% Price Change
Belysse Group NV produces and sells textile floor coverings for commercial and residential applications in Europe, North America, and internationally. The company designs, manufactures, and distributes broadloom carpets and modular carpet tiles primarily for offices and public projects. It commercializes its products under the Bentley, modulyss, arc edition, and ITC brands. The company was formerly known as Balta Group NV and changed its name to Belysse Group NV in October 2022. Belysse Group NV was founded in 1964 and is headquartered in Waregem, Belgium. Belysse Group NV is a subsidiary of LSF9 Belysse Holdco S.à r.l.
BEL 20 ended the session with BELYSSE GROUP dropping 7.32% to €0.76 on Friday, after two consecutive sessions in a row of gains. BEL 20 rose 0.42% to €3,733.99, after two consecutive sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, BELYSSE GROUP has a trailing twelve months EPS of €-0.31.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BELYSSE GROUP’s stock is considered to be oversold (<=20).
More news about BELYSSE GROUP.
10. EUTELSAT COMMUNIC. (ETL.PA)
-6.75% Price Change
Eutelsat Group, together with its subsidiaries, engages in the operation of telecommunication satellites. It provides capacity for video services, fixed data, and government services; and capacity in connectivity applications, such as fixed broadband and mobile connectivity. The company offers its services under the Eutelsat brand directly and through distributors. It operates 36 satellites in geostationary orbit. The company serves satellite-based video, business and broadband networks, and mobile services mainly to international telecommunications operators and broadcasters, corporate network integrators, companies, telecom operators, and government agencies in France, Italy, the United Kingdom, rest of Europe, the Americas, the Middle East, Africa, Asia, and internationally. The company was formerly known as Eutelsat Communications S.A. and changed its name to Eutelsat Group in October 2023. Eutelsat Group was founded in 1977 and is headquartered in Issy-les-Moulineaux, France.
CAC 40 ended the session with EUTELSAT COMMUNIC. falling 6.75% to €3.65 on Friday, after five consecutive sessions in a row of gains. CAC 40 rose 0.15% to €8,028.01, after two successive sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, EUTELSAT COMMUNIC. has a trailing twelve months EPS of €0.52.
PE Ratio
EUTELSAT COMMUNIC. has a trailing twelve months price to earnings ratio of 7.02. Meaning, the purchaser of the share is investing €7.02 for every euro of annual earnings.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EUTELSAT COMMUNIC.’s stock is considered to be oversold (<=20).
Volume
Today’s last reported volume for EUTELSAT COMMUNIC. is 311771 which is 12.1% below its average volume of 354703.
More news about EUTELSAT COMMUNIC..
Stay up to date with our winners and losers daily report
